3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
145
Lymphoma, Follicular
41
Lymphoma, Large B-Cell, Diffuse
36
Lymphoma, B-Cell, Marginal Zone
24
Recurrence
17
Lymphoma, Mantle-Cell
17
Lymphoma
16
Neoplasms, Plasma Cell
15
Lymphoma, Non-Hodgkin
15
Leukemia, Lymphocytic, Chronic, B-Cell
11
Neoplasms
9
Lymphoma, B-Cell
8
Smoldering Multiple Myeloma
7
Burkitt Lymphoma
5
Neoplasm, Residual
4
Leukemia, Plasma Cell
4
Waldenstrom Macroglobulinemia
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell, Cutaneous
3
Plasmacytoma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Lymphoma, T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Urinary Bladder Neoplasms
1
Interventions
Injections
20
Carboplatin
9
pembrolizumab
8
Bevacizumab
6
Pemetrexed
5
Paclitaxel
5
Leucovorin
5
Fluorouracil
5
fludarabine
4
Oxaliplatin
4
Docetaxel
4
sotorasib
3
atezolizumab
3
Drug Therapy
3
Cyclophosphamide
3
Capecitabine
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
spartalizumab
2
palbociclib
2
olaparib
2
Panitumumab
2
Immune Checkpoint Inhibitors
2
Fulvestrant
2
Etoposide
2
Cisplatin
2
Cetuximab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
Lenalidomide
×
1 year
×
Clear all
No trials found.